EUVIMEDEUVIMED entdecken
Crossref

Initial clinical outcomes of robotic resection for perihilar cholangiocarcinoma: Is it safe and effective?

Trenton Lippert, Sharona Ross, Tara Pattilachan, Maria Christodoulou, Denis Gratsianskiy, Alexander Rosemurgy, Iswanto Sucandy

Journal of Surgical Oncology · 2024

DOI: 10.1002/jso.27676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Trenton Lippert und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, University of South Florida Morsani, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Klatskin Tumor, Bile Duct Neoplasms, Hepatectomy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives We aimed to describe our outcomes of robotic resection for perihilar cholangiocarcinoma, the largest single institutional series in the Western hemisphere to date.

Methods

Between 2016 and 2022, we prospectively followed all patients who underwent robotic resection for perihilar cholangiocarcinoma.

Results

In total, 23 patients underwent robotic resection for perihilar cholangiocarcinoma, 18 receiving concomitant hepatectomy. The median age was 73 years. Operative time was 470 min with an estimated blood loss of 150 mL. No intraoperative conversions to open or other intraoperative complications occurred. Median length of stay was 5 days. Four postoperative complications occurred. Three readmissions occurred within 30 days with one 90‐day mortality. R0 resection was achieved in 87% of patients and R1 in 13% of patients. At a median follow‐up of 27 months, 15 patients were alive without evidence of disease, two patients with local recurrence at 1 year, and six were deceased.

Conclusions

Utilization of the robotic platform for perihilar cholangiocarcinoma is safe and feasible with excellent perioperative outcomes. Further studies are needed to determine the long‐term oncological outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Robotic Surgical ProceduresKlatskin TumorBile Duct NeoplasmsHepatectomyHumansMaleFemaleAgedMiddle AgedProspective StudiesAged, 80 and overPostoperative ComplicationsFollow-Up StudiesTreatment OutcomeLength of StayOperative Time

Stichwörter der Autor:innen

Hilar cholangiocarcinoma resectionKlatskin tumorminimally invasive liver surgeryperihilar cholangiocarcinomarobotic bile duct cancer surgery

Autor:innen und Institutionen

  • College of Medicine, University of South Florida Morsani, Tampa, Florida, USA.
  • AdventHealth Digestive Health Institute, Tampa, Florida, USA.

Zitieren

APA

Lippert, T., Ross, S., Pattilachan, T., Christodoulou, M., Gratsianskiy, D., Rosemurgy, A., & Sucandy, I. (2024). Initial clinical outcomes of robotic resection for perihilar cholangiocarcinoma: Is it safe and effective?. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27676

Vancouver

Lippert T, Ross S, Pattilachan T, Christodoulou M, Gratsianskiy D, Rosemurgy A, et al. Initial clinical outcomes of robotic resection for perihilar cholangiocarcinoma: Is it safe and effective?. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27676

BibTeX
@article{Lippert2024,
  author = {Lippert, Trenton and Ross, Sharona and Pattilachan, Tara and Christodoulou, Maria and Gratsianskiy, Denis and Rosemurgy, Alexander and Sucandy, Iswanto},
  title = {Initial clinical outcomes of robotic resection for perihilar cholangiocarcinoma: Is it safe and effective?},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1002/jso.27676}
}
Kostenlos starten →